文献速递类风湿关节炎脊柱关节炎其他结缔组织病

类风湿关节炎、银屑病及银屑病关节炎患者心血管危险因素的患病率与发病率

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2017-09-07

基于MarketScan数据库2002至2014年医疗与药房索赔数据,识别类风湿关节炎(RA)、银屑病及银屑病关节炎(PsA)患者,估计高血压、糖尿病、高脂血症和肥胖的年龄性别标准化患病率及随访期间每1000患者年的发病率。结果显示三类患者心血管危险因素患病率和发病率均较高,提示需对这些患者进行危险因素监测。

要点

  • RA、银屑病和PsA患者高血压患病率分别为18.6%、16.6%和19.9%。
  • RA、银屑病和PsA患者高血压发病率分别为每1000患者年74.0、68.2和79.8。
  • 三类患者糖尿病、高脂血症和肥胖的患病率与发病率亦较高。

核心结论

  • RA、银屑病和PsA患者心血管危险因素患病率和发病率均较高,提示需要对这些患者进行危险因素监测。

研究设计与样本

  • 基于MarketScan索赔数据库2002年1月1日至2014年12月31日医疗和药房索赔数据识别RA、银屑病或PsA患者。
  • 主要结局为诊断日期前12个月心血管危险因素的年龄和性别标准化患病率,以及随访期间每1000患者年的发病率(含95%CI)。

主要发现

  • RA、银屑病和PsA队列高血压患病率分别为18.6%(95%CI 18.3-18.8)、16.6%(95%CI 16.3-17.0)和19.9%(95%CI 19.4-20.4)。
  • RA、银屑病和PsA队列糖尿病患病率分别为6.2%(95%CI 6.1-6.4)、6.3%(95%CI 6.0-6.5)和7.8%(95%CI 7.4-8.2)。
  • RA、银屑病和PsA队列高脂血症患病率分别为9.9%(95%CI 9.7-10.1)、10.4%(95%CI 10.2-10.7)和11.6%(95%CI 11.2-12.0)。
  • RA、银屑病和PsA队列肥胖患病率分别为4.4%(95%CI 4.2-4.6)、3.8%(95%CI 3.5-4.0)和6.0%(95%CI 5.6-6.5)。
  • 随访期间RA、银屑病和PsA队列高血压发病率分别为每1000患者年74.0(95%CI 72.5-75.5)、68.2(95%CI 65.9-70.4)和79.8(95%CI 76.3-83.3)。

关键数值与推荐

  • RA、银屑病和PsA队列糖尿病发病率分别为每1000患者年10.6(95%CI 10.1-11.1)、13.0(95%CI 12.1-13.8)和14.7(95%CI 13.5-16.0)。
  • RA、银屑病和PsA队列高脂血症发病率分别为每1000患者年40.3(95%CI 39.4-41.3)、47.1(95%CI 45.4-48.7)和52.0(95%CI 49.6-54.3)。
  • RA、银屑病和PsA队列肥胖发病率分别为每1000患者年24.4(95%CI 23.4-25.4)、26.4(95%CI 25.0-27.8)和32.9(95%CI 30.6-35.2)。

临床怎么用

  • 对RA、银屑病和PsA患者应监测高血压、糖尿病、高脂血症和肥胖等心血管危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate prevalence and incidence of cardiovascular (CV) risk factors of hypertension, diabetes mellitus, hyperlipidemia, and obesity in patients with rheumatoid arthritis (RA), psoriasis, or psoriatic arthritis (PsA). METHODS: Patients with RA, psoriasis, or PsA were identified based on medical and pharmacy claims from the MarketScan claims databases from January 1, 2002 through December 31, 2014. Primary outcomes included age- and sex-standardized prevalence of CV risk factors during the 12 months preceding diagnosis date and incidence rates per 1,000 patient-years, with 95% confidence intervals (95% CIs) during followup. RESULTS: Prevalence for RA, psoriasis, and PsA cohorts for hypertension was 18.6% (95% CI 18.3-18.8), 16.6% (95% CI 16.3-17.0), and 19.9% (95% CI 19.4-20.4), respectively; for diabetes mellitus 6.2% (95% CI 6.1-6.4), 6.3% (95% CI 6.0-6.5), and 7.8% (95% CI 7.4-8.2); for hyperlipidemia 9.9% (95% CI 9.7-10.1), 10.4% (95% CI 10.2-10.7), and 11.6% (95% CI 11.2-12.0); and for obesity 4.4% (95% CI 4.2-4.6), 3.8% (95% CI 3.5-4.0), and 6.0% (95% CI 5.6-6.5). Incidence rates per 1,000 patient-years during followup for RA, psoriasis, and PsA cohorts, respectively, for hypertension were 74.0 (95% CI 72.5-75.5), 68.2 (95% CI 65.9-70.4), and 79.8 (95% CI 76.3-83.3); for diabetes mellitus 10.6 (95% CI 10.1-11.1), 13.0 (95% CI 12.1-13.8), and 14.7 (95% CI 13.5-16.0); for hyperlipidemia 40.3 (95% CI 39.4-41.3), 47.1 (95% CI 45.4-48.7), and 52.0 (95% CI 49.6-54.3); and for obesity 24.4 (95% CI 23.4-25.4), 26.4 (95% CI 25.0-27.8), and 32.9 (95% CI 30.6-35.2). CONCLUSION: Patients with RA, psoriasis, and PsA have high prevalence and incidence of CV risk factors, suggesting the need for risk factor monitoring of these patients.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Radner H, Lesperance T, Accortt NA, et al. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2017. PMID: 27998029. doi:10.1002/acr.23171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。